Cure Quick Pharma Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 15-12-2024
- Paid Up Capital ₹ 3.80 M
as on 15-12-2024
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 8.80 Cr
as on 15-12-2024
- Revenue -64.86%
(FY 2021)
- Profit -129.46%
(FY 2021)
- Ebitda -61.25%
(FY 2021)
- Net Worth -1.14%
(FY 2021)
- Total Assets -39.41%
(FY 2021)
About Cure Quick Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.80 M.
The company currently has active open charges totaling ₹8.80 Cr.
Harish Digani and Siddharth serve as directors at the Company.
- CIN/LLPIN
U24100DL2015PTC287272
- Company No.
287272
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Nov 2015
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cure Quick Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harish Digani  | Director | 09-Nov-2015 | Current |
| Siddharth | Director | 18-Jan-2024 | Current |
Financial Performance of Cure Quick Pharma.
Cure Quick Pharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 64.86% decrease. The company also saw a substantial fall in profitability, with a 129.46% decrease in profit. The company's net worth dipped by a decrease of 1.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cure Quick Pharma?
In 2021, Cure Quick Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cure Quick Remedies Private LimitedActive 23 years 4 monthsHarish Digani and Siddharth are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 24 Jun 2020 | ₹8.80 Cr | Open |
How Many Employees Work at Cure Quick Pharma?
Unlock and access historical data on people associated with Cure Quick Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cure Quick Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cure Quick Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
